[Investigation of rectal and bladder complications after RALS therapy for carcinoma of the uterine cervix].
From August 1978 through December, 1980, 119 patients with previously untreated carcinoma of the uterine cervix were treated using RALS, (remote-controlled) high dose rate intracavitary radiotherapy. The data from 92 out of the 119 cases were available for multivariate analysis for rectovesical complications. By using this method, it was clearly indicated that factors such as TDF of the rectum, weighted geometric center (WGC)-Z, the dose of whole pelvic irradiation, chemotherapy and TPHA were important in the occurrence of rectal complications. However, there was no definite physical or physiological factor to predict the occurrence of bladder complications.
D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001918:Brachytherapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011336:Probability; D011832:Radiation Injuries / Q000453:epidemiology*; D011879:Radiotherapy Dosage; D012002:Rectal Diseases / Q000453:epidemiology*; D001745:Urinary Bladder Diseases / Q000453:epidemiology*; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*